FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
If the FDA's decision on Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences in 2026 is a full approval or an accelerated approval, the answer is Yes.
What's your call?
Nobody has called this yet. Yours could be the first. Voting closes Jan 1.
Question and outcome: Kalshi. CallItPoll is not affiliated with Kalshi and runs no betting or trading.